GPR37 and myeloid sarcoma: A strong and global GPR37 down-regulation was observed in the MS WM (**** p < 0.0001; Figure 5G), which was consistently seen across all MS subtypes (**** p < 0.0001 for RRMS, *** p < 0.001 for SPMS and PPMS, respectively; Figure 5G′).